LB
41
7
STT
64
4
PCAR
56
3
ITW
62
4
AIG
44
6
SIG
49
6
FITB
60
2
RIG
58
4
PH
73
3
JNJ
44
3
PBI
65
5
BAX
30
4
IFF
56
3
GT
56
2
STZ
57
2
FRT
45
6
CMG
67
3
ISRG
76
2
K
57
4
A
41
5
LB
41
7
STT
64
4
PCAR
56
3
ITW
62
4
AIG
44
6
SIG
49
6
FITB
60
2
RIG
58
4
PH
73
3
JNJ
44
3
PBI
65
5
BAX
30
4
IFF
56
3
GT
56
2
STZ
57
2
FRT
45
6
CMG
67
3
ISRG
76
2
K
57
4
A
41
5
Financhill
Back

Neurocrine Biosciences 10K Form

Buy
57

NBIX
Neurocrine Biosciences

Last Price:
125.67
Seasonality Move:
17.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01 10Q NBIX/Neurocrine Biosciences Quarterly
2023-10-31 10Q NBIX/Neurocrine Biosciences Quarterly
2023-08-01 10Q NBIX/Neurocrine Biosciences Quarterly
2023-05-03 10Q NBIX/Neurocrine Biosciences Quarterly
2022-11-01 10Q NBIX/Neurocrine Biosciences Quarterly
2022-08-04 10Q NBIX/Neurocrine Biosciences Quarterly

Receive NBIX News And Ratings

See the #1 stock for the next 7 days that we like better than NBIX

NBIX Financial Statistics

Sales & Book Value

Annual Sales: $1.89B
Cash Flow: $149.9M
Price / Cash Flow: 29.4
Annual Sales: $26.87
Price / Book: 4.65

Profitability

EPS (TTM): 3.73000
Net Income (TTM): $385.9M
Gross Margin: $1.85B
Return on Equity: 16.29%
Return on Assets: 11.76%

Neurocrine Biosciences Earnings Forecast

Key Neurocrine Biosciences Financial Ratios

  • The Gross Profit Margin over the past 28 years for NBIX is 97.90%.
  • The Selling, General & Administrative Expenses for NBIX have been equal to 47.04% of Gross Profit Margin.
  • The Research & Development expenses have been 29.94% of Revenue.
  • The Interest Expense is 1.84% of Operating Income.
  • The Net Earning history of NBIX is 13.23% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 13 years.

Neurocrine Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NBIX
CUSIP: 64125C
Website: neurocrine.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.37
Quick Ratio: 3.98

Price-to-Earnings

Trailing P/E Ratio: 50.61
Forward P/E Ratio: 16.29

NBIX Technical Analysis vs Fundamental Analysis

Buy
57
Neurocrine Biosciences (NBIX) is a Buy

Is Neurocrine Biosciences a Buy or a Sell?